2 commercial payer policies list S1658. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
2 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of S1658 |
|---|---|---|
| Cellular Therapy Products for Allogeneic Stem Cell Transplantation | Oct 1, 2026 | Covered |
| Hematopoietic Stem Cell Transplantation for Multiple Myeloma and Other Plasma Cell Dyscrasias | Jan 6, 2026 | Covered |